Company Long-Term Liabilities: Qilian International Holding Group (QLI)

Graphic logo of Qilian International Corp (QLI)

Export flows for Qilian International (QLI) are under pressure due to trade disputes between Washington and Beijing, which threaten to restrict access to Western investment. The market perceives the asset as speculative due to its limited global presence. The business relies on the production of licorice extracts, utilizing government licenses to protect its market share. The current figure stands at 0.00, and a detailed price chart of long-term debt is provided below.

QLI qlsyy.net: Company Long-Term Liabilities in the range 07/04/2022 - 08/17/2024
Manufactured product of Qilian International Holding Group

Asset managers require an objective assessment of credit load to analyze business sustainability. This indicator measures the total volume of liabilities with a maturity of over one year, determining the company's financial leverage. By analyzing the trend of the issuer's long-term liabilities, an investor evaluates the balance between growth and default risk. For Qilian International (QLI), this reflects the costs of maintaining integrated raw material supply chains. Debt optimization ensures the seamless operation of regional pharmaceutical logistics hubs.

Who Qilian International competes with

Company Long-Term Loans and Borrowings HLN|KVUE - Company Long-Term Debt|Verona Pharma PLC (VRNA) - Company Long-Term Liabilities|MENS: Company Long-Term Debts|Ligand Corp (LGND) - Company Long-Term Debts|Company Long-Term Liabilities AMRX|PRGO: Company Long-Term Loans and Borrowings|Company Long-Term Debt Alvotech SA (ALVO)|LQDA - Long-Term Debt|Galapagos Genomics - Company Long-Term Liabilities|Amount of Long-Term Liabilities ANIP (ANI Pharmaceuticals Corp)|MannKind Corporation - Company Long-Term Debts|Company Long-Term Loans and Borrowings AMPH (amphastar.com)|PCRX: Company Long-Term Debts|Long-Term Debt ARS Pharmaceuticals Inc (SPRY)|Company Long-Term Debt Theravance|AQST: Company Long-Term Loans and Borrowings|Company Long-Term Debt scPharmaceuticals Inc. (SCPH)|tectonictx.com (TECX) - Long-Term Indebtedness|Company Long-Term Debts TNXP (Tonix Pharmaceuticals Holding Corp.)|Long-Term Debt Volume SXT Pharmaceuticals (SXTC)|EPRX - Company Long-Term Debt|BHST: Company Long-Term Debt|EXOZ: Company Long-Term Debts|ORMP - Long-Term Debt Volume|ENTX (Entera Bio Ltd) - Company Long-Term Debts|Company Long-Term Debts MindWalk Holdings, Inc.|Company Long-Term Debt ABVC BioPharma Inc (ABVC)|Cumberland Corp - Company Long-Term Indebtedness|Quantum BioPharma Ltd - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings FGEN|Telomir Pharmaceuticals, Inc. - Company Long-Term Debts|Long-Term Debt Volume Rani Therapeutics RANI|synergychc.com (SNYR) - Company Long-Term Debt|Company Long-Term Indebtedness RLYB|Company Long-Term Liabilities LEXX|PULM (pulmatrix.com) - Amount of Long-Term Liabilities|Company Long-Term Debts PTHL|APM - Long-Term Debt|Company Long-Term Debt Lyra Therapeutics, Inc LYRA|Company Long-Term Loans and Borrowings IBO|TNFA - Company Long-Term Debt|YCBD (cbdMD, Inc.) - Company Long-Term Indebtedness|PRFX: Company Long-Term Debts|Altamira Therapeutics Ltd. (CYTO) - Company Long-Term Debts|Company Long-Term Liabilities LIPO|OPTN (OptiNose Corp) - Amount of Long-Term Liabilities|Company Long-Term Debts PIRS|Long-Term Debt Volume procapsgroup.com|Company Long-Term Debt Petros Pharmaceuticals, Inc. PTPI|Acelyrin Inc. (SLRN) - Long-Term Debt|TFFP - Company Long-Term Debt